Our healthcare system is methodically assimilating the age of electronic information, despite several barriers to widespread adoption for physicians. One key aspect of this trend centers on e-prescribing. In terms of safety, ease of use, and savings of time and cost, is e-prescribing a viable option? Host Dr. Jay Goldstein examines the issue and its effect on the GI practice with Dr. Peter Kaufman, a partner in the Metropolitan GI Group based in greater Washington, DC, and chief medical officer of DrFirst, a company specializing in electronic prescribing.
Electronic Prescribing and the GI Practice
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Our healthcare system is methodically assimilating the age of electronic information, despite several barriers to widespread adoption for physicians. One key aspect of this trend centers on e-prescribing. In terms of safety, ease of use, and savings of time and cost, is e-prescribing a viable option? Host Dr. Jay Goldstein examines the issue and its effect on the GI practice with Dr. Peter Kaufman, a partner in the Metropolitan GI Group based in greater Washington, DC, and chief medical officer of DrFirst, a company specializing in electronic prescribing.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
0.25 credits
<p>Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management</p>
CME/CE
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
0.25 credits
<p>Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities</p>
Project Oncology®
Targeting CD123 in AML: The Latest Therapeutic Advancements
<p>Targeting CD123 in AML: The Latest Therapeutic Advancements</p>
On the Frontlines of Osteoporosis
Breaking Ground in Bone Health: Key Takeaways from ISO 2025
<p>Breaking Ground in Bone Health: Key Takeaways from ISO 2025</p>
ACC Action Center
Lorundrostat lowers BP in uncontrolled and treatment-resistant hypertension
<p>Lorundrostat lowers BP in uncontrolled and treatment-resistant hypertension</p>
ACC Action Center
Fluid restriction may not be needed in chronic HF
<p>Fluid restriction may not be needed in chronic HF</p>
ACC Action Center
Mobile integrated health program in patients with HF
<p>Mobile integrated health program in patients with HF</p>
Modern Aesthetics
MATV NEWS: Dr. Saami Khalifian Discusses New Allergan Aesthetics AMI Training Centers and More
<p>MATV NEWS: Dr. Saami Khalifian Discusses New Allergan Aesthetics AMI Training Centers and More</p>
<p> </p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?